Homocysteine induces blood vessel global hypomethylation mediated by LOX-1

Genetics and Molecular Research

Volumn 13, Issue 2, 2014, Pages 3787-3799

  Yang, X L ^a   Tian, J ^a   Liang, Y ^a   Ma, C J ^a   Yang, A N ^a   Wang, J ^a   Ma, S C ^a   Cheng, Y ^a   Hua, X ^a   Jiang, Y D ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Global DNA methylation; Homocysteine; Lectin like oxidized LDL receptor 1

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; LIPID; OLR1 PROTEIN, MOUSE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL GLOBAL METHYLATION; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; ENDOTHELIUM CELL; GENE EXPRESSION; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LOX 1 GENE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BLOOD; BLOOD VESSEL; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TOXICITY;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD VESSELS; DNA METHYLATION; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; LIPIDS; MICE; SCAVENGER RECEPTORS, CLASS E;

EID: 84900853664     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.May.16.2     Document Type: Article

References (24)

1. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, et al. (2002). Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol. Cell. Biol. 22: 2124-2135.
2. Castro R, Rivera I, Struys EA, Jansen EE, et al. (2003). Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49: 1292-1296.
3. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, et al. (2004). Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23: 8841-8846.
4. Delgado-Cruzata L, Wu HC, Perrin M, Liao Y, et al. (2012). Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the breast cancer family registry. Epigenetics 7: 868-874.
5. Du X, Han L, Guo AY and Zhao Z (2012). Features of methylation and gene expression in the promoter-associated CpG islands using human methylome data. Comp. Funct. Genomics 2012: 598987.
6. Duthie SJ, Grant G, Pirie LP, Watson AJ, et al. (2010). Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev. Res. 3: 92-100.
7. King WD, Ho V, Dodds L, Perkins SL, et al. (2012). Relationships among biomarkers of one-carbon metabolism. Mol. Biol. Rep. 39: 7805-7812.
8. Kinney SR and Pradhan S (2011). Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog. Mol. Biol. Transl. Sci. 101: 311-333.
9. Kirsch SH, Knapp JP, Geisel J, Herrmann W, et al. (2009). Simultaneous quantification of S-adenosyl methionine and S-adenosyl homocysteine in human plasma by stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 3865-3870.
10. MacLean KN, Greiner LS, Evans JR, Sood SK, et al. (2012). Cystathionine protects against endoplasmic reticulum stress-induced lipid accumulation, tissue injury, and apoptotic cell death. J. Biol. Chem. 287: 31994-32005.
11. Moarefi AH and Chedin F (2011). ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation. J. Mol. Biol. 409: 758-772.
12. Morawietz H (2010). LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis. Dtsch Med. Wochenschr 135: 308-312.
13. Munjal C, Tyagi N, Lominadze D and Tyagi SC (2012). Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability. J. Cell Biochem. 113: 1159-1169.
14. Pazienza V, Tavano F, Benegiamo G, Vinciguerra M, et al. (2012). Correlations among PPARgamma, DNMT1, and DNMT3B expression levels and pancreatic cancer. PPAR Res. 2012: 461784.
15. Rapava EA, Akhvlediani MV and Emukhvari MG (2006). Modern view on biochemistry of atherosclerosis. Georgian Med. News 124-128.
16. Saunthararajah Y, Triozzi P, Rini B, Singh A, et al. (2012). p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies. Semin. Oncol. 39: 97-108.
17. Suter CM, Martin DI and Ward RL (2004). Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 19: 95-101.
18. Tehlivets O (2011). Homocysteine as a risk factor for atherosclerosis: is its conversion to S-adenosyl-L-homocysteine the key to deregulated lipid metabolism? J. Lipids 2011: 702853.
19. Thampi P, Stewart BW, Joseph L, Melnyk SB, et al. (2008). Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression. Atherosclerosis 197: 620-629.
20. Turcot V, Tchernof A, Deshaies Y, Perusse L, et al. (2012). LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin. Epigenetics 4: 10.
21. Wernimont SM, Clark AG, Stover PJ, Wells MT, et al. (2011). Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study. BMC Med. Genet. 12: 150.
22. Yates PA, Burman RW, Mummaneni P, Krussel S, et al. (1999). Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J. Biol. Chem. 274: 36357-36361.
23. Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, et al. (2011). The discovery of LOX-1, its ligands and clinical significance. Cardiovasc. Drugs Ther. 25: 379-391.
24. Yung RL and Julius A (2008). Epigenetics, aging, and autoimmunity. Autoimmunity 41: 329-335.